Hardy Diagnostics hires research and development manager
Will accelerate entry into new molecular markets
Crowe will lead the company’s r&d and team in developing products for the diagnostic laboratory. He was recently involved in launching a product line for the molecular biology market known as CulGenex.
In addition, Crowe is expanding Hardy Diagnostics’ line of chromogenic media, which detect bacteria quickly and easily due to a colour change produced by the organisms after coming into contact with the culture media.
Jay Hardy, president of Hardy Diagnostics, said Crowe’s knowledge of molecular biology techniques would accelerate the firm’s entry into new markets.
You may also like
Analysis
Advanced analytics: Driving cleanroom excellence in pharmaceutical manufacturing
Cleanrooms are essential in the pharmaceutical industry, providing controlled environments for the aseptic production of sterile products. Recently, big data analytics has emerged as a transformative tool, offering new ways to enhance cleanroom performance beyond traditional methods